| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| Nov 24, 2025 |
Ultragenyx Pharmaceutical Inc.
RARE
|
BUY |
$50.00
Est. +49%
|
$33.59 | $39.89 |
Pending
|
$24.35
-27.5%
|
| Nov 11, 2025 |
4D Molecular Therapeutics Inc
FDMT
|
BUY |
$33.00
Est. +224%
|
$10.17 | $11.89 |
Pending
|
$8.83
-13.2%
|
| Nov 05, 2025 |
PTC Therapeutics Inc
PTCT
|
BUY |
$68.00
Est. +0%
|
$67.72 | $87.23 |
Target Met
|
$75.14
+11.0%
|
| Nov 04, 2025 |
Vertex Pharmaceuticals, Inc.
VRTX
|
SELL |
$414.00
Est. +3%
|
$426.00 | $403.16 (Low) |
Precision Hit (±3%)
|
$444.93
-4.4%
|
| Oct 28, 2025 |
Intellia Therapeutics Inc
NTLA
|
BUY |
$24.00
Est. +62%
|
$14.79 | $17.09 |
Pending
|
$12.11
-18.1%
|
| Oct 17, 2025 |
Cellectis - ADR
CLLS
|
BUY |
$8.00
Est. +77%
|
$4.52 | $5.36 |
Pending
|
$3.09
-31.6%
|
| Oct 06, 2025 |
Cytokinetics Inc
CYTK
|
BUY |
$82.00
Est. +44%
|
$56.97 | $80.18 |
Precision Hit (±3%)
|
$70.15
+23.1%
|
| Sep 25, 2025 |
Kodiak Sciences Inc
KOD
|
BUY |
$17.00
Est. +10%
|
$15.49 | $47.84 |
Target Met
|
$34.06
+119.9%
|
| Sep 23, 2025 |
Ionis Pharmaceuticals Inc
IONS
|
BUY |
$82.00
Est. +34%
|
$61.36 | $86.74 |
Target Met
|
$73.28
+19.4%
|
| Sep 03, 2025 |
Cytokinetics Inc
CYTK
|
BUY |
$71.00
Est. +42%
|
$49.99 | $80.18 |
Target Met
|
$70.15
+40.3%
|
| Sep 02, 2025 |
Ionis Pharmaceuticals Inc
IONS
|
BUY |
$78.00
Est. +36%
|
$57.49 | $86.74 |
Target Met
|
$73.28
+27.5%
|
| Jul 22, 2025 |
Sarepta Therapeutics Inc
SRPT
|
BUY |
$18.00
Est. +35%
|
$13.32 | $25.32 |
Target Met
|
$15.31
+14.9%
|
| Apr 24, 2025 |
Cytokinetics Inc
CYTK
|
BUY |
$55.00
Est. +36%
|
$40.33 | $70.98 |
Target Met
|
$70.15
+73.9%
|
| Nov 05, 2024 |
Editas Medicine Inc
EDIT
|
BUY |
$5.00
Est. +60%
|
$3.12 | $4.54 |
Miss
|
$2.50
-19.9%
|
| Oct 15, 2024 |
Legend Biotech Corp - ADR
LEGN
|
BUY |
$94.00
Est. +108%
|
$45.25 | $51.77 |
Miss
|
$35.87
-20.7%
|
| Oct 04, 2024 |
Biomarin Pharmaceutical Inc. - Registered Shares
BMRN
|
BUY |
$86.00
Est. +24%
|
$69.51 | $73.51 |
Miss
|
$55.95
-19.5%
|
| Sep 16, 2024 |
Biomarin Pharmaceutical Inc. - Registered Shares
BMRN
|
BUY |
$110.00
Est. +57%
|
$69.86 | $77.60 |
Miss
|
$55.95
-19.9%
|
| Aug 08, 2024 |
Sarepta Therapeutics Inc
SRPT
|
BUY |
$203.00
Est. +45%
|
$140.06 | $144.22 |
Miss
|
$15.31
-89.1%
|
| Aug 06, 2024 |
Biocryst Pharmaceuticals Inc.
BCRX
|
SELL |
$7.00
Est. +7%
|
$7.51 | $6.02 (Low) |
Target Met
|
$8.70
-15.8%
|
| Aug 02, 2024 |
Vir Biotechnology Inc
VIR
|
BUY |
$28.00
Est. +188%
|
$9.73 | $14.45 |
Miss
|
$8.61
-11.5%
|
| Jun 13, 2024 |
Sarepta Therapeutics Inc
SRPT
|
BUY |
$185.00
Est. +54%
|
$119.98 | $155.95 |
Miss
|
$15.31
-87.2%
|
| May 21, 2024 |
Vir Biotechnology Inc
VIR
|
BUY |
$27.00
Est. +179%
|
$9.69 | $14.45 |
Miss
|
$8.61
-11.1%
|
| May 16, 2024 |
Solid Biosciences Inc
SLDB
|
BUY |
$18.00
Est. +86%
|
$9.69 | $10.37 |
Miss
|
$7.14
-26.3%
|
| Apr 15, 2024 |
4D Molecular Therapeutics Inc
FDMT
|
BUY |
$45.00
Est. +71%
|
$26.35 | $28.93 |
Miss
|
$8.83
-66.5%
|
| Nov 02, 2022 |
Arcturus Therapeutics Holdings Inc
ARCT
|
BUY |
$25.00
Est. +15%
|
$21.69 | - | - |
$6.97
-67.9%
|
| Aug 23, 2022 |
Biocryst Pharmaceuticals Inc.
BCRX
|
SELL |
$14.00
Est. +2%
|
$14.33 | - | - |
$8.70
+39.3%
|
| Aug 22, 2022 |
Bluebird bio Inc
BLUE
|
SELL |
$5.00
Est. +14%
|
$5.83 | $55.60 (Low) |
Miss
|
$4.97
+14.8%
|
| Feb 24, 2022 |
Moderna Inc
MRNA
|
BUY |
$210.00
Est. +34%
|
$156.23 | - | - |
$49.91
-68.1%
|
| Feb 10, 2022 |
Seagen Inc
SGEN
|
SELL |
$120.00
Est. +4%
|
$124.93 | - | - |
$228.74
-83.1%
|
| Nov 04, 2021 |
Ionis Pharmaceuticals Inc
IONS
|
SELL |
$33.00
Est. +5%
|
$34.63 | - | - |
$73.28
-111.6%
|
| Oct 28, 2021 |
Alnylam Pharmaceuticals Inc
ALNY
|
BUY |
$210.00
Est. +30%
|
$162.14 | - | - |
$282.85
+74.4%
|
| Aug 05, 2021 |
Intellia Therapeutics Inc
NTLA
|
BUY |
$207.00
Est. +25%
|
$165.16 | - | - |
$12.11
-92.7%
|
| Aug 03, 2021 |
Ultragenyx Pharmaceutical Inc.
RARE
|
BUY |
$141.00
Est. +68%
|
$83.77 | - | - |
$24.35
-70.9%
|
| Jun 11, 2021 |
Vertex Pharmaceuticals, Inc.
VRTX
|
BUY |
$285.00
Est. +48%
|
$193.02 | - | - |
$444.93
+130.5%
|